XML 24 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statement Of Stockholders' Equity - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Paid-in Capital
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2020     141,900,000        
Beginning balance at Dec. 31, 2020 $ 1,297.1 $ 19.2 $ 1.4 $ 3,204.9 $ (1,813.4) $ 19.2 $ (95.8)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 988.6       988.6    
Equity-based compensation expense 72.6     72.6      
Stock option exercises (in shares)     1,500,000        
Stock option exercises 69.9     69.9      
Coworker Stock Purchase Plan (in shares)     100,000        
Coworker Stock Purchase Plan 20.6     20.6      
Repurchases of common stock (in shares)     (8,700,000)        
Repurchases of common stock (1,500.4)   $ (0.1)   (1,500.3)    
Dividend payments (234.8)     1.5 (236.3)    
Incentive compensation plan stock withheld for taxes (28.5)       (28.5)    
Unrealized loss on cash flow hedge 0.0            
Reclassification of cash flow hedge to net income 2.5           2.5
Foreign currency translation (1.1)           (1.1)
Ending balance (in shares) at Dec. 31, 2021     134,800,000        
Ending balance at Dec. 31, 2021 705.7   $ 1.3 3,369.5 (2,570.7)   (94.4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 1,114.5       1,114.5    
Equity-based compensation expense 91.1     91.1      
Stock option exercises (in shares)     500,000        
Stock option exercises 30.2   $ 0.1 30.1      
Coworker Stock Purchase Plan (in shares)     200,000        
Coworker Stock Purchase Plan 25.5     25.5      
Dividend payments (282.6)     1.9 (284.5)    
Incentive compensation plan stock withheld for taxes (23.1)       (23.1)    
Unrealized loss on cash flow hedge (0.1)           (0.1)
Reclassification of cash flow hedge to net income 3.6           3.6
Foreign currency translation (61.5)           (61.5)
Ending balance (in shares) at Dec. 31, 2022     135,500,000        
Ending balance at Dec. 31, 2022 1,603.3   $ 1.4 3,518.1 (1,763.8)   (152.4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 1,104.3       1,104.3    
Equity-based compensation expense $ 93.7     93.7      
Stock option exercises (in shares) 714,538   1,000,000.0        
Stock option exercises $ 49.3     49.3      
Coworker Stock Purchase Plan (in shares)     200,000        
Coworker Stock Purchase Plan 28.2     28.2      
Repurchases of common stock (in shares)     (2,600,000)        
Repurchases of common stock (500.0)   $ (0.1)   (499.9)    
Dividend payments (321.5)     2.0 (323.5)    
Incentive compensation plan stock withheld for taxes (40.0)       (40.0)    
Unrealized loss on cash flow hedge (1.9)           (1.9)
Reclassification of cash flow hedge to net income 0.0            
Foreign currency translation 27.1       (2.6)   29.7
Ending balance (in shares) at Dec. 31, 2023     134,100,000        
Ending balance at Dec. 31, 2023 $ 2,042.5   $ 1.3 $ 3,691.3 $ (1,525.5)   $ (124.6)